Close

Peptide VSV

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

  • TCR Cell Products

Loading...
  • Cell Type:
  • Target:
  • HLA:
  • Epitope:
CAT Product Name Cell Type Target HLA Epitope Inquiry & Datasheet
TCRJ-YC1361 Anti-Peptide VSV (IGYVYQGL) T Cell Receptor (N30.7 TCRα), Jurkat Cell Line T lymphocyte Peptide VSV H2-Kb IGYVYQGL   Add to Cart   Datasheet
TCRJ-YC1362 Anti-Peptide VSV (KGYVYQGL) T Cell Receptor (N30.7 TCRα), Jurkat Cell Line T lymphocyte Peptide VSV H2-Kb KGYVYQGL   Add to Cart   Datasheet
TCRJ-YC1363 Anti-Peptide VSV (RGYVYDGL) T Cell Receptor (N30.7 TCRα), Jurkat Cell Line T lymphocyte Peptide VSV H2-Kb RGYVYDGL   Add to Cart   Datasheet
TCRJ-YC1364 Anti-Peptide VSV (RGYVYEGL) T Cell Receptor (N30.7 TCRα), Jurkat Cell Line T lymphocyte Peptide VSV H2-Kb RGYVYEGL   Add to Cart   Datasheet
TCRJ-YC1365 Anti-Peptide VSV (RGYVYIGL) T Cell Receptor (N30.7 TCRα), Jurkat Cell Line T lymphocyte Peptide VSV H2-Kb RGYVYIGL   Add to Cart   Datasheet
TCRJ-YC1366 Anti-Peptide VSV (RGYVYKGL) T Cell Receptor (N30.7 TCRα), Jurkat Cell Line T lymphocyte Peptide VSV H2-Kb RGYVYKGL   Add to Cart   Datasheet
TCRJ-YC1367 Anti-Peptide VSV (RGYVYMGL) T Cell Receptor (N30.7 TCRα), Jurkat Cell Line T lymphocyte Peptide VSV H2-Kb RGYVYMGL   Add to Cart   Datasheet
TCRJ-YC1368 Anti-Peptide VSV (RGYVYRGL) T Cell Receptor (N30.7 TCRα), Jurkat Cell Line T lymphocyte Peptide VSV H2-Kb RGYVYRGL   Add to Cart   Datasheet
TCRJ-YC1369 Anti-Peptide VSV (IGYVYQGL) T Cell Receptor (YC60), Jurkat Cell Line T lymphocyte Peptide VSV H2-Kb IGYVYQGL   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.